{"id":9531,"date":"2024-10-16T16:49:31","date_gmt":"2024-10-16T14:49:31","guid":{"rendered":"https:\/\/syva.es\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/"},"modified":"2024-12-10T23:34:19","modified_gmt":"2024-12-10T22:34:19","slug":"syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd","status":"publish","type":"post","link":"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/","title":{"rendered":"Syvac\u00ae EH Marker: the first and unique DIVA vaccine against EHD"},"content":{"rendered":"<p><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\"><strong>The AEMPS authorises Syvac\u00ae EH Marker, the first and only DIVA vaccine against Epizootic Haemorrhagic Epizootic Disease (EHD) virus from Syva<\/strong><\/span> PRESS RELEASE: <span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Le\u00f3n \u2013 Technology Parc \u2013 Spain, 16 October 2024<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Syva is pleased to announce that the Spanish Agency for Medicines and Health Products has authorized the emergency use of its DIVA vaccine against EHD in accordance with Article 110 (2) of Regulation (EU) 2019\/6 in cattle and deer.<\/span><\/strong><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">SYVAC\u00ae EH Marker is the first and unique subunit vaccine against this disease available on the European market. This innovative process using \u2018subunit\u2019 technology allows differentiation between infected and vaccinated animals, a benefit for the control of this emerging disease. <\/span><\/p>\n<h5 class=\"cvGsUA direction-ltr align-justify para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Epizootic haemorrhagic disease, a silent but very real threat in Europe!<\/span><\/strong><\/h5>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">The first cases of serotype 8 epizootic haemorrhagic disease were reported in November 2022, in Italy. Almost at the same time, outbreaks were detected in southern Spain, in Extremadura and Andalusia, spreading soon after to a large number of farms all over Spain. Later, in September 2023, France reported the first outbreaks of the disease.  <\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Although it does not affect humans, EHD is one of the vector-borne diseases, caused by an Orbivirus similar to Bluetongue, whose serotype 3 (BTV3) was identified in 2023 in Europe and that has recently been detected in Spain, severely affecting ruminants, especially sheep and cattle.<\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Vaccination is the most effective method to prevent and control both Bluetongue and Epizootic Haemorrhagic Disease, and in the case of EHD, having a DIVA vaccine available for the first time in Europe is a step forward and a key innovation for the control of the disease.<\/span><\/p>\n<h5 class=\"cvGsUA direction-ltr align-justify para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">EHD serotype 8 vaccine: Syva opts for innovation and DIVA technology.<\/span><\/strong><\/h5>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Syva decided to provide an innovative vaccine with a decisive added value that is enabling a DIVA strategy to be implemented in the future, offering to veterinarians and livestock farmers a useful and effective tool in the battle against this epizootic.<\/span><\/p>\n<h5 class=\"cvGsUA direction-ltr align-justify para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">But what is a DIVA vaccine?<\/span><\/strong><\/h5>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">DIVA stands for \u2018Differentiation between Infected and Vaccinated Animals\u2019. Syvac\u00ae EH Marker is based on so-called subunit technology. A subunit vaccine only contains parts (or \u2018subunits\u2019) of a virus or bacteria, rather than the entire micro-organism. These subunits are virus-specific proteins that the immune system can recognise to trigger the desired immune response in the vaccinated animals.   <\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Marker vaccines induce an immune response different from the one induced by a natural infection. In the context of EHD, as in other notifiable diseases, Syvac\u00ae EH Marker means a turning point in the fight against the disease. <\/span><\/p>\n<p> Download here the <strong><a href=\"https:\/\/syva.es\/wp-content\/uploads\/2024\/10\/SYVAC-EH-MARKER-DIVA-VACUNA-Autorizacion-ESPANA-nota-de-prensa-16-10-2024.pdf\">Press release<\/a><\/strong><\/p>\n<h5 class=\"cvGsUA direction-ltr align-justify para-style-body\"><strong><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-underline text-strikethrough-none\">ABOUT Syvac<sup>\u00ae<\/sup> EH Marker<\/span><\/strong><\/h5>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">Syvac<sup>\u00ae<\/sup> EH Marker <\/span>injectable emulsion <span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">is the first and only subunit vaccine that provides differentiated protection against EHD in cattle and deer. It is the only EHDV vaccine on the EU market that currently allows differentiation between infected and non-infected animals. Furthermore, it is conveniently administered in 2 ml intramuscular doses.  <\/span><\/p>\n<p class=\"cvGsUA direction-ltr align-justify para-style-body\"><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">For more information, <\/span><a class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-underline text-strikethrough-none\" draggable=\"false\" href=\"https:\/\/syva.es\/producto\/syvac-eh-marker-emulsion-inyectable\/\" target=\"_blank\" rel=\"noopener\">see the product page on our website <\/a><span class=\"OYPEnA font-feature-liga-off font-feature-clig-off font-feature-calt-off text-decoration-none text-strikethrough-none\">.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PRESS RELEASE &#8211; Syva is pleased to announce that the Spanish Agency for Medicines and Health Products has authorized the emergency use of its DIVA vaccine against EHD in accordance with Article 110 (2) of Regulation (EU) 2019\/6 in cattle and deer. SYVAC\u00ae EH Marker is the first and unique subunit vaccine against this disease available on the European market. <\/p>\n","protected":false},"author":4,"featured_media":9525,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_lmt_disableupdate":"no","_lmt_disable":"","footnotes":""},"categories":[789,791,797,793,2176,805,803,799,53],"tags":[2198,2135,2201,2240,2204,2205,2197,2278,2196,2200,2206,2277,2279,2199,2202,2108,2203],"class_list":["post-9531","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-animal-welfare","category-corporate-en","category-export","category-in-focus","category-press-release","category-syva-in-the-world","category-syvastart-en","category-the-syva-award","category-uncategorized","tag-aemps-en","tag-animal-health","tag-art-110-en","tag-bluetongue","tag-cattle","tag-deer","tag-diva-en","tag-diva-vaccine","tag-ehd","tag-emergency-use","tag-emerging-disease","tag-epizootic-haemorrhagic-disease","tag-epizooty","tag-serotypo-8","tag-subunit-en","tag-vaccine","tag-vp2-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Syvac\u00ae EH Marker: the first and unique DIVA vaccine against EHD - Syva<\/title>\n<meta name=\"description\" content=\"PRESS RELEASE Syva is pleased to announce that the Spanish Agency for Medicines and Health Products (AEMPS) has authorised the temporary use of its DIVA vaccine against EHE in accordance with Article 110(2) of Regulation (EU) 2019\/6 in cattle and deer. SYVAC\u00ae EH Marker is the first and only subunit vaccine available on the European market against this disease.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Syvac\u00ae EH Marker: the first and unique DIVA vaccine against EHD - Syva\" \/>\n<meta property=\"og:description\" content=\"PRESS RELEASE Syva is pleased to announce that the Spanish Agency for Medicines and Health Products (AEMPS) has authorised the temporary use of its DIVA vaccine against EHE in accordance with Article 110(2) of Regulation (EU) 2019\/6 in cattle and deer. SYVAC\u00ae EH Marker is the first and only subunit vaccine available on the European market against this disease.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/\" \/>\n<meta property=\"og:site_name\" content=\"Syva\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-16T14:49:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-10T22:34:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/syva.es\/wp-content\/uploads\/2024\/10\/AdobeStock_423200400-1400pix-Photo-CP-Banner.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1400\" \/>\n\t<meta property=\"og:image:height\" content=\"658\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Caroline De Siron\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Caroline De Siron\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/\"},\"author\":{\"name\":\"Caroline De Siron\",\"@id\":\"https:\/\/syva.es\/en\/#\/schema\/person\/b0533ddea617c5f83a24ca71d8152052\"},\"headline\":\"Syvac\u00ae EH Marker: the first and unique DIVA vaccine against EHD\",\"datePublished\":\"2024-10-16T14:49:31+00:00\",\"dateModified\":\"2024-12-10T22:34:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/\"},\"wordCount\":490,\"publisher\":{\"@id\":\"https:\/\/syva.es\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/syva.es\/wp-content\/uploads\/2024\/10\/AdobeStock_423200400-1400pix-Photo-CP-Banner.jpeg\",\"keywords\":[\"AEMPS\",\"Animal Health\",\"Art 110\",\"Bluetongue\",\"Cattle\",\"Deer\",\"DIVA\",\"Diva Vaccine\",\"EHD\",\"emergency use\",\"emerging disease\",\"Epizootic Haemorrhagic Disease\",\"epizooty\",\"serotypo 8\",\"Subunit\",\"vaccine\",\"VP2\"],\"articleSection\":[\"Animal welfare\",\"Corporate\",\"Export\",\"In Focus\",\"Press release\",\"Syva in the world\",\"SyvaStart\",\"The Syva Award\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/\",\"url\":\"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/\",\"name\":\"Syvac\u00ae EH Marker: the first and unique DIVA vaccine against EHD - Syva\",\"isPartOf\":{\"@id\":\"https:\/\/syva.es\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/syva.es\/wp-content\/uploads\/2024\/10\/AdobeStock_423200400-1400pix-Photo-CP-Banner.jpeg\",\"datePublished\":\"2024-10-16T14:49:31+00:00\",\"dateModified\":\"2024-12-10T22:34:19+00:00\",\"description\":\"PRESS RELEASE Syva is pleased to announce that the Spanish Agency for Medicines and Health Products (AEMPS) has authorised the temporary use of its DIVA vaccine against EHE in accordance with Article 110(2) of Regulation (EU) 2019\/6 in cattle and deer. SYVAC\u00ae EH Marker is the first and only subunit vaccine available on the European market against this disease.\",\"breadcrumb\":{\"@id\":\"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/#primaryimage\",\"url\":\"https:\/\/syva.es\/wp-content\/uploads\/2024\/10\/AdobeStock_423200400-1400pix-Photo-CP-Banner.jpeg\",\"contentUrl\":\"https:\/\/syva.es\/wp-content\/uploads\/2024\/10\/AdobeStock_423200400-1400pix-Photo-CP-Banner.jpeg\",\"width\":1400,\"height\":658},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/syva.es\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Syvac\u00ae EH Marker: the first and unique DIVA vaccine against EHD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/syva.es\/en\/#website\",\"url\":\"https:\/\/syva.es\/en\/\",\"name\":\"Syva\",\"description\":\"Soluciones con sentido para la salud animal\",\"publisher\":{\"@id\":\"https:\/\/syva.es\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/syva.es\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/syva.es\/en\/#organization\",\"name\":\"Syva\",\"url\":\"https:\/\/syva.es\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/syva.es\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/syva.es\/wp-content\/uploads\/2019\/11\/syva-favicon.png\",\"contentUrl\":\"https:\/\/syva.es\/wp-content\/uploads\/2019\/11\/syva-favicon.png\",\"width\":512,\"height\":512,\"caption\":\"Syva\"},\"image\":{\"@id\":\"https:\/\/syva.es\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/syva.es\/en\/#\/schema\/person\/b0533ddea617c5f83a24ca71d8152052\",\"name\":\"Caroline De Siron\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/syva.es\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1860af197c9ab5760253262956f1e263?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1860af197c9ab5760253262956f1e263?s=96&d=mm&r=g\",\"caption\":\"Caroline De Siron\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Syvac\u00ae EH Marker: the first and unique DIVA vaccine against EHD - Syva","description":"PRESS RELEASE Syva is pleased to announce that the Spanish Agency for Medicines and Health Products (AEMPS) has authorised the temporary use of its DIVA vaccine against EHE in accordance with Article 110(2) of Regulation (EU) 2019\/6 in cattle and deer. SYVAC\u00ae EH Marker is the first and only subunit vaccine available on the European market against this disease.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/","og_locale":"en_US","og_type":"article","og_title":"Syvac\u00ae EH Marker: the first and unique DIVA vaccine against EHD - Syva","og_description":"PRESS RELEASE Syva is pleased to announce that the Spanish Agency for Medicines and Health Products (AEMPS) has authorised the temporary use of its DIVA vaccine against EHE in accordance with Article 110(2) of Regulation (EU) 2019\/6 in cattle and deer. SYVAC\u00ae EH Marker is the first and only subunit vaccine available on the European market against this disease.","og_url":"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/","og_site_name":"Syva","article_published_time":"2024-10-16T14:49:31+00:00","article_modified_time":"2024-12-10T22:34:19+00:00","og_image":[{"width":1400,"height":658,"url":"https:\/\/syva.es\/wp-content\/uploads\/2024\/10\/AdobeStock_423200400-1400pix-Photo-CP-Banner.jpeg","type":"image\/jpeg"}],"author":"Caroline De Siron","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Caroline De Siron","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/#article","isPartOf":{"@id":"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/"},"author":{"name":"Caroline De Siron","@id":"https:\/\/syva.es\/en\/#\/schema\/person\/b0533ddea617c5f83a24ca71d8152052"},"headline":"Syvac\u00ae EH Marker: the first and unique DIVA vaccine against EHD","datePublished":"2024-10-16T14:49:31+00:00","dateModified":"2024-12-10T22:34:19+00:00","mainEntityOfPage":{"@id":"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/"},"wordCount":490,"publisher":{"@id":"https:\/\/syva.es\/en\/#organization"},"image":{"@id":"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/#primaryimage"},"thumbnailUrl":"https:\/\/syva.es\/wp-content\/uploads\/2024\/10\/AdobeStock_423200400-1400pix-Photo-CP-Banner.jpeg","keywords":["AEMPS","Animal Health","Art 110","Bluetongue","Cattle","Deer","DIVA","Diva Vaccine","EHD","emergency use","emerging disease","Epizootic Haemorrhagic Disease","epizooty","serotypo 8","Subunit","vaccine","VP2"],"articleSection":["Animal welfare","Corporate","Export","In Focus","Press release","Syva in the world","SyvaStart","The Syva Award"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/","url":"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/","name":"Syvac\u00ae EH Marker: the first and unique DIVA vaccine against EHD - Syva","isPartOf":{"@id":"https:\/\/syva.es\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/#primaryimage"},"image":{"@id":"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/#primaryimage"},"thumbnailUrl":"https:\/\/syva.es\/wp-content\/uploads\/2024\/10\/AdobeStock_423200400-1400pix-Photo-CP-Banner.jpeg","datePublished":"2024-10-16T14:49:31+00:00","dateModified":"2024-12-10T22:34:19+00:00","description":"PRESS RELEASE Syva is pleased to announce that the Spanish Agency for Medicines and Health Products (AEMPS) has authorised the temporary use of its DIVA vaccine against EHE in accordance with Article 110(2) of Regulation (EU) 2019\/6 in cattle and deer. SYVAC\u00ae EH Marker is the first and only subunit vaccine available on the European market against this disease.","breadcrumb":{"@id":"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/#primaryimage","url":"https:\/\/syva.es\/wp-content\/uploads\/2024\/10\/AdobeStock_423200400-1400pix-Photo-CP-Banner.jpeg","contentUrl":"https:\/\/syva.es\/wp-content\/uploads\/2024\/10\/AdobeStock_423200400-1400pix-Photo-CP-Banner.jpeg","width":1400,"height":658},{"@type":"BreadcrumbList","@id":"https:\/\/syva.es\/en\/syvac-eh-marker-the-first-and-unique-diva-vaccine-against-ehd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/syva.es\/en\/"},{"@type":"ListItem","position":2,"name":"Syvac\u00ae EH Marker: the first and unique DIVA vaccine against EHD"}]},{"@type":"WebSite","@id":"https:\/\/syva.es\/en\/#website","url":"https:\/\/syva.es\/en\/","name":"Syva","description":"Soluciones con sentido para la salud animal","publisher":{"@id":"https:\/\/syva.es\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/syva.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/syva.es\/en\/#organization","name":"Syva","url":"https:\/\/syva.es\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/syva.es\/en\/#\/schema\/logo\/image\/","url":"https:\/\/syva.es\/wp-content\/uploads\/2019\/11\/syva-favicon.png","contentUrl":"https:\/\/syva.es\/wp-content\/uploads\/2019\/11\/syva-favicon.png","width":512,"height":512,"caption":"Syva"},"image":{"@id":"https:\/\/syva.es\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/syva.es\/en\/#\/schema\/person\/b0533ddea617c5f83a24ca71d8152052","name":"Caroline De Siron","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/syva.es\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1860af197c9ab5760253262956f1e263?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1860af197c9ab5760253262956f1e263?s=96&d=mm&r=g","caption":"Caroline De Siron"}}]}},"modified_by":"Caroline De Siron","_links":{"self":[{"href":"https:\/\/syva.es\/en\/wp-json\/wp\/v2\/posts\/9531","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/syva.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/syva.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/syva.es\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/syva.es\/en\/wp-json\/wp\/v2\/comments?post=9531"}],"version-history":[{"count":3,"href":"https:\/\/syva.es\/en\/wp-json\/wp\/v2\/posts\/9531\/revisions"}],"predecessor-version":[{"id":9656,"href":"https:\/\/syva.es\/en\/wp-json\/wp\/v2\/posts\/9531\/revisions\/9656"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/syva.es\/en\/wp-json\/wp\/v2\/media\/9525"}],"wp:attachment":[{"href":"https:\/\/syva.es\/en\/wp-json\/wp\/v2\/media?parent=9531"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/syva.es\/en\/wp-json\/wp\/v2\/categories?post=9531"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/syva.es\/en\/wp-json\/wp\/v2\/tags?post=9531"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}